Page last updated: 2024-09-04

vx 497 and Adjuvant Arthritis

vx 497 has been researched along with Adjuvant Arthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrish, JC; Bednarz, MS; Berry, KK; Chen, BC; Cheney, DL; Dhar, TG; Fleener, CA; Gu, HH; Guo, J; Harper, TW; Hollenbaugh, DL; Iwanowicz, EJ; Liu, C; MacMaster, JF; McIntyre, KW; Miller, LM; Pitts, WJ; Rouleau, KA; Shen, Z; Sherbina, NZ; Shuster, DJ; Tredup, JA; Watterson, SH; Witmer, MR; Zhao, R	1

Other Studies

1 other study(ies) available for vx 497 and Adjuvant Arthritis

Article	Year
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity. Journal of medicinal chemistry, 2002, May-23, Volume: 45, Issue:11 Topics: Animals; Antibody Formation; Arthritis, Experimental; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; IMP Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Morpholines; Mycophenolic Acid; Oxazoles; Rats; Rats, Inbred Lew; Structure-Activity Relationship	2002

Article

Year

Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.

Journal of medicinal chemistry, 2002, May-23, Volume: 45, Issue:11

Topics: Animals; Antibody Formation; Arthritis, Experimental; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; IMP Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Morpholines; Mycophenolic Acid; Oxazoles; Rats; Rats, Inbred Lew; Structure-Activity Relationship

2002